Skip to main content
. 2015 Dec 1;4:743. doi: 10.1186/s40064-015-1545-y

Fig. 1.

Fig. 1

Kaplan-Meier curves for median progression-free survival (PFS) of advanced gastric cancer patients in group A (three-drugs first-line chemotherapy) (dotted line) and group B (two-drugs first-line chemotherapy) (thin line) (7.3 vs. 4.5 months, p = 0.0007)